Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Lol

<< Previous

Bullboard Posts

Next >>

Comment by Rarbar99on Aug 19, 2021 3:05pm

149 Views

Post# 33734209

RE:RE:Lol

You keep dissing Yukon as if he didn't own you.

I’ve read your history and you were arguing with Yukon since this stock was in the $4 range. You kept calling him a fudfairy and making fun of him, along with several other bears like Dustin.

This stock crashed 70% and you still have the nerve to talk?

And just so you know, I said all of those things when this stock was $1.30-1.50

Check the price now. It’s going down to $1 just like I said.

You are a loser who is clearly angry that he didn’t take profits when he had the chance. Sucks to suck. Stop talking about Yukon as if he's not your father.

<< Previous

Bullboard Posts

Next >>

Day trading vs. swing trading strategies for small-cap stocks